)
DaVita (DVA) investor relations material
DaVita TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Financial performance and guidance
Projected 2026 operating income (OI) growth slightly above the low end of long-term targets, driven by 1.5% growth from U.S. dialysis and 1% each from international and IKC segments.
Revenue growth is expected to come from revenue per treatment, with flat volume and steady margins; cost control remains a focus.
Free cash flow is guided to be flat year-over-year, with variability attributed to working capital swings rather than fundamental business changes.
Enhanced premium tax credit (APTC) expiration is expected to create $40 million pressure in 2024, $70 million in 2025, and $10 million in 2028, mainly impacting new patient commercial mix.
OI growth is expected to remain in the 3%-7% range, with double-digit EPS growth and disciplined capital deployment.
Operational initiatives and cost management
Margin maintenance is prioritized even without volume growth, leveraging cost controls, revenue operations, and evolving opportunities in labor, pharma, and G&A.
New IT systems for labor scheduling and ongoing investments in IT are expected to help flatten G&A growth and potentially turn it into a margin tailwind.
Clinical programs targeting mortality and volume growth include flu vaccination, GLP-1 utilization, and middle molecule management, with major impacts expected by 2029.
Most clinical program investments are IT-focused rather than capital-intensive, and require collaboration with physicians and patients.
Capacity utilization is expected to improve through volume growth rather than clinic closures, with margin leverage greatest when filling existing shifts.
Market dynamics and risk factors
Commercial mix remains stable, with exchange growth as the main driver; no significant changes expected outside of APTC impacts.
GLP-1s are expected to have a neutral impact on admissions and a modest headwind to commercial mix, estimated at 3 basis points per year.
Supply chain risks are being addressed through enhanced business continuity planning following recent disruptions.
International operations are diverse, with clinical improvements in every country and capital spending focused on organic growth and select acquisitions.
Legal and regulatory issues such as AB 290 and Marietta SCOTUS remain unresolved but have not caused recent disruptions.
Next DaVita earnings date
Next DaVita earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)